{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T01:38:40Z","timestamp":1791855520648,"version":"4.3.4"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.2215\/cjn.13071212","type":"journal-article","created":{"date-parts":[[2013,11,21]],"date-time":"2013-11-21T23:07:12Z","timestamp":1385075232000},"page":"271-278","source":"Crossref","is-referenced-by-count":32,"title":["Cyclosporine C2 Monitoring for the Treatment of Frequently Relapsing Nephrotic Syndrome in Children"],"prefix":"10.2215","volume":"9","author":[{"given":"Kazumoto","family":"Iijima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayumi","family":"Sako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari Saito","family":"Oba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Hataya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryojiro","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Ohwada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Kamei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Ishikura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahoko","family":"Yata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kandai","family":"Nozu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Honda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidefumi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michio","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norishige","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20230601","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(03)14184-0","article-title":"Nephrotic syndrome in childhood.","volume":"362","author":"Eddy","year":"2003","journal-title":"Lancet"},{"key":"R2-10-20230601","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s004670050558","article-title":"Two-year cyclosporin treatment in children with steroid-dependent nephrotic syndrome.","volume":"13","author":"Inoue","year":"1999","journal-title":"Pediatr Nephrol"},{"key":"R3-10-20230601","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/BF00853209","article-title":"Long-term ciclosporin treatment in children with steroid-dependent nephrotic syndrome.","volume":"7","author":"Tanaka","year":"1993","journal-title":"Pediatr Nephrol"},{"key":"R4-10-20230601","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/BF00869823","article-title":"Ciclosporin treatment in children with steroid-dependent nephrotic syndrome.","volume":"4","author":"Kitano","year":"1990","journal-title":"Pediatr Nephrol"},{"key":"R5-10-20230601","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1093\/ndt\/gfi059","article-title":"Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: A single-centre experience.","volume":"20","author":"El-Husseini","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"R6-10-20230601","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1038\/sj.ki.5002553","article-title":"Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome: Workshop recommendations.","volume":"72","author":"Cattran","year":"2007","journal-title":"Kidney Int"},{"key":"R8-10-20230601","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/ki.2008.24","article-title":"Effective and safe treatment with cyclosporine in nephrotic children: A prospective, randomized multicenter trial.","volume":"73","author":"Ishikura","year":"2008","journal-title":"Kidney Int"},{"key":"R9-10-20230601","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1093\/ndt\/gfq318","article-title":"Treatment with microemulsified cyclosporine in children with frequently relapsing nephrotic syndrome.","volume":"25","author":"Ishikura","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"R10-10-20230601","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/00007691-200408000-00012","article-title":"Cyclosporin A absorption profiles in pediatric renal transplant recipients predict the risk of acute rejection.","volume":"26","author":"Weber","year":"2004","journal-title":"Ther Drug Monit"},{"key":"R11-10-20230601","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1097\/01.TP.0000160762.37225.2B","article-title":"Pharmacokinetic of cyclosporine microemulsion in pediatric kidney recipients receiving A quadruple immunosuppressive regimen: The value of C2 blood levels.","volume":"79","author":"Ferraresso","year":"2005","journal-title":"Transplantation"},{"key":"R12-10-20230601","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1097\/01.tp.0000268306.41196.2c","article-title":"The clinical benefits of cyclosporine C2-level monitoring: A systematic review.","volume":"83","author":"Knight","year":"2007","journal-title":"Transplantation"},{"key":"R13-10-20230601","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00467-011-2076-6","article-title":"Nephrotoxicity of once-daily cyclosporine A in minimal change nephrotic syndrome.","volume":"27","author":"Fujinaga","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"R14-10-20230601","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1525-1594.2009.00838.x","article-title":"Effect of cyclosporine therapy with low doses of corticosteroids on idiopathic nephrotic syndrome.","volume":"34","author":"Griveas","year":"2010","journal-title":"Artif Organs"},{"key":"R15-10-20230601","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.2215\/CJN.01520209","article-title":"Risk factors for cyclosporin A nephrotoxicity in children with steroid-dependant nephrotic syndrome.","volume":"4","author":"Kengne-Wafo","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"R16-10-20230601","doi-asserted-by":"crossref","first-page":"84","DOI":"10.5414\/CNP69084","article-title":"Is single-daily low-dose cyclosporine therapy really effective in children with idiopathic frequent-relapsing nephrotic syndrome?","volume":"69","author":"Fujinaga","year":"2008","journal-title":"Clin Nephrol"},{"key":"R17-10-20230601","doi-asserted-by":"crossref","first-page":"258","DOI":"10.5414\/CNP64258","article-title":"C1-C2 point monitoring of low-dose cyclosporin a given as a single daily dose in children with steroid-dependent relapsing nephrotic syndrome.","volume":"64","author":"Nakahata","year":"2005","journal-title":"Clin Nephrol"},{"key":"R18-10-20230601","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1007\/s00467-005-1932-7","article-title":"Preprandial C2 monitoring of cyclosporine treatment in children with nephrotic syndrome.","volume":"20","author":"Fujinaga","year":"2005","journal-title":"Pediatr Nephrol"},{"key":"R19-10-20230601","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1620\/tjem.209.191","article-title":"Renal biopsy findings in children receiving long-term treatment with cyclosporine a given as a single daily dose.","volume":"209","author":"Tanaka","year":"2006","journal-title":"Tohoku J Exp Med"},{"key":"R20-10-20230601","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1620\/tjem.220.183","article-title":"Benefits of once-daily administration of cyclosporine a for children with steroid-dependent, relapsing nephrotic syndrome.","volume":"220","author":"Suzuki","year":"2010","journal-title":"Tohoku J Exp Med"},{"key":"R23-10-20230601","first-page":"1375","article-title":"Randomized phase II clinical trials.","volume":"69","author":"Simon","year":"1985","journal-title":"Cancer Treat Rep"},{"key":"R24-10-20230601","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/sim.704","article-title":"A flexible design for multiple armed screening trials.","volume":"20","author":"Sargent","year":"2001","journal-title":"Stat Med"},{"key":"R25-10-20230601","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1093\/ndt\/gfn013","article-title":"Nephrotic state as a risk factor for developing posterior reversible encephalopathy syndrome in paediatric patients with nephrotic syndrome.","volume":"23","author":"Ishikura","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"R26-10-20230601","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00431-011-1633-0","article-title":"Age effect on whole blood cyclosporine concentrations following oral administration in children with nephrotic syndrome.","volume":"171","author":"Ushijima","year":"2012","journal-title":"Eur J Pediatr"},{"key":"R27-10-20230601","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1034\/j.1399-0012.2002.02036.x","article-title":"Two-hour post-dose cyclosporine level is a better predictor than trough level of acute rejection of renal allografts.","volume":"16","author":"Pescovitz","year":"2002","journal-title":"Clin Transplant"},{"key":"R28-10-20230601","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1097\/01.TP.0000068868.01424.61","article-title":"Clinical benefits of neoral C2 monitoring in the long-term management of renal transplant recipients.","volume":"75","author":"Cole","year":"2003","journal-title":"Transplantation"},{"key":"R29-10-20230601","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1034\/j.1399-3046.2003.00077.x","article-title":"Longitudinal evaluation of the pharmacokinetics of cyclosporin microemulsion (Neoral) in pediatric renal transplant recipients and assessment of C2 level as a marker for absorption.","volume":"7","author":"Trompeter","year":"2003","journal-title":"Pediatr Transplant"},{"key":"R30-10-20230601","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1681\/ASN.V124828","article-title":"Approaching the therapeutic window for cyclosporine in kidney transplantation: A prospective study.","volume":"12","author":"Mahalati","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"R31-10-20230601","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1034\/j.1600-6143.2002.20814.x","article-title":"Adequate early cyclosporin exposure is critical to prevent renal allograft rejection: Patients monitored by absorption profiling.","volume":"2","author":"Clase","year":"2002","journal-title":"Am J Transplant"},{"key":"R32-10-20230601","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1399-0012.2008.00837.x","article-title":"Risk factors for acute rejection in renal transplant recipients experiencing delayed graft function.","volume":"22","author":"Moore","year":"2008","journal-title":"Clin Transplant"},{"key":"R33-10-20230601","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1093\/ndt\/gfh819","article-title":"Limitations of C2 monitoring in renal transplant recipients.","volume":"20","author":"Einecke","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"R34-10-20230601","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1097\/01.tp.0000203306.72858.df","article-title":"Early cyclosporine C0 and C2 monitoring in de novo kidney transplant patients: A prospective randomized single-center pilot study.","volume":"81","author":"Kyll\u00f6nen","year":"2006","journal-title":"Transplantation"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201402000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:43:58Z","timestamp":1786369438000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201402000-00010"}},"subtitle":["A Multicenter Randomized Phase II Trial"],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.13071212","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]}}}